Most neurologists treat people who have Parkinson’s disease with a medication called carbidopa/levodopa or Sinemet, as it is known by its brand name. We also offer several new FDA-approved therapies, surgery and other therapies that can greatly improve the quality of a patient’s life.
Recommendations will depend upon the course of the disease, the patient’s medical history and the neurologist’s estimation of which option is best for this particular patient.
New FDA-approved Parkinson’s therapies
Neurologists typically use these therapies in more advanced Parkinson’s disease or in special circumstances. Both therapies aim to increase “on” time, while reducing “off” time. “On” time refers to periods when Parkinson’s symptoms are adequately controlled. “Off” time refers to periods of the day when the medication is not working well, making symptoms worse. Continue reading →
According to the Parkinson’s Disease Foundation, approximately 7 to 10 million people live with Parkinson’s disease. Naturally, patients and families want to learn more about the best medications and treatments for this life-changing illness. This article concerns medications that may help or control the poor motor symptoms associated with Parkinson’s. These symptoms can include tremor, slow movement, stiffness, difficulty with gait and posture, and a feeling of weakness.
Best medicine: Exercise
It is a fact that the patients who exercise do so much better than those who don’t. Recent research has suggested that even simple daily activities, such as routine housework, can provide benefit in motor symptoms. This should be paired with exercise, as well.
I believe that all patients with Parkinson’s disease should be involved in scheduled, safe exercise. It’s as good as any medication we can provide. Continue reading →
University of Michigan’s Dr. Daniel Orringer with the new SRS microscope which promises to make brain tumor and other cancer surgeries safer and more efficient
Here at the University of Michigan we are testing a new microscope that will radically change brain tumor surgery—making it safer and more efficient. So far, we have used the microscope on tissues from 89 patients with great success.
Timing and location are important
One of the most difficult things for a brain surgeon is figuring out exactly where a brain tumor starts and stops because brain tumor tissue can be hard to distinguish from the rest of the brain. The new stimulated Raman scattering (SRS) microscope allows us to see the edges of a tumor in a few seconds instead of waiting the 30-45 minutes it usually takes for a frozen tumor section to be developed.
Right now, we are using the microscope on an experimental basis through grants from the National Institutes of Health and the University of Michigan Translational Research and Commercialization for Life Sciences Program. We are using the microscope almost exclusively on neurosurgical cases. I’m also collaborating with Matt Spector, who is a head and neck surgeon, to look at squamous cell carcinoma. Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.